An updated meta-analysis of endothelial nitric oxide synthase gene: Three well-characterized polymorphisms with hypertension

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Niu, Wenquan ^a,b   Qi, Yue ^c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Chinese Academy of Sciences   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASIAN; CHINESE; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE; ETHNICITY; GENE; GENE FREQUENCY; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); PROMOTER REGION; PUBLICATION; RISK ASSESSMENT; EXON; FEMALE; GENETICS; INTRON; MALE; META ANALYSIS; MIDDLE AGED;

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

EXONS; FEMALE; HUMANS; HYPERTENSION; INTRONS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC;

EID: 80052423663     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024266     Document Type: Article

References (55)

1. Williams RR, Hunt SC, Hasstedt SJ, Hopkins PN, Wu LL, et al. (1991) Are there interactions and relations between genetic and environmental factors predisposing to high blood pressure? Hypertension 18: I29-I37.
2. Niu W, Wu S, Zhang Y, Li W, Ji K, et al. (2010) Validation of genetic association in apelin-AGTRL1 system with hypertension in a larger Han Chinese population. J Hypertens 28: 1854-1861.
3. Zhuo ML, Huang Y, Chen JZ, Sun LH, Yang RF, et al. (2009) Endothelium-specific overexpression of human IC53 downregulates endothelial nitric oxide synthase activity and elevates systolic blood pressure in mice. Cardiovasc Res 84: 292-299.
4. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, et al. (1995) Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242.
5. Ohashi Y, Kawashima S, Hirata K, Yamashita T, Ishida T, et al. (1998) Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. J Clin Invest 102: 2061-2071.
6. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR, (2009) Introduction to Meta-Analysis. John Wiley & Sons, Ltd.
7. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
8. Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, Shimasaki Y, et al. (1998) Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32: 3-8.
9. Lacolley P, Gautier S, Poirier O, Pannier B, Cambien F, et al. (1998) Nitric oxide synthase gene polymorphisms, blood pressure and aortic stiffness in normotensive and hypertensive subjects. J Hypertens 16: 31-35.
10. Kato N, Sugiyama T, Morita H, Nabika T, Kurihara H, et al. (1999) Lack of evidence for association between the endothelial nitric oxide synthase gene and hypertension. Hypertension 33: 933-936.
11. Uwabo J, Soma M, Nakayama T, Kanmatsuse K, (1998) Association of a variable number of tandem repeats in the endothelial constitutive nitric oxide synthase gene with essential hypertension in Japanese. Am J Hypertens 11: 125-128.
12. Benjafield AV, Morris BJ, (2000) Association analyses of endothelial nitric oxide synthase gene polymorphisms in essential hypertension. Am J Hypertens 13: 994-998.
13. Shoji M, Tsutaya S, Saito R, Takamatu H, Yasujima M, (2000) Positive association of endothelial nitric oxide synthase gene polymorphism with hypertension in northern Japan. Life Sci 66: 2557-2562.
14. Kajiyama N, Saito Y, Miyamoto Y, Yoshimura M, Nakayama M, et al. (2000) Lack of association between T-786->C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene and essential hypertension. Hypertens Res 23: 561-565.
15. Chen W, Srinivasan SR, Elkasabany A, Ellsworth DL, Boerwinkle E, Berenson GS, (2001) Combined effects of endothelial nitric oxide synthase gene polymorphism (G894T) and insulin resistance status on blood pressure and familial risk of hypertension in young adults: the Bogalusa Heart Study. Am J Hypertens 14: 1046-1052.
16. Jáchymová M, Horký K, Bultas J, Kozich V, Jindra A, et al. (2001) Association of the Glu298Asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy. Biochem Biophys Res Commun 284: 426-430.
17. Tsujita Y, Baba S, Yamauchi R, Mannami T, Kinoshita M, et al. (2001) Association analyses between genetic polymorphisms of endothelial nitric oxide synthase gene and hypertension in Japanese: The Suita Study. J Hypertens 19: 1941-1948.
18. Ukkola O, Erkkilä PH, Savolainen MJ, Kesäniemi YA, (2001) Lack of association between polymorphisms of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus. J Intern Med 249: 451-459.
19. Karvonen J, Kauma H, Kervinen K, Rantala M, Ikäheimo M, et al. (2002) Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort. J Intern Med 251: 102-110.
20. Hyndman ME, Parsons HG, Verma S, Bridge PJ, Edworthy S, et al. (2002) The T-786->C mutation in endothelial nitric oxide synthase is associated with hypertension. Hypertension 39: 919-922.
21. Grandone E, Colaizzo D, Martinelli P, Pavone G, Errico M, et al. (2003) Does endothelial nitric oxide synthase gene variation play a role in the occurrence of hypertension in pregnancy? Hypertens Pregnancy 22: 149-155.
22. Rodríguez-Esparragón FJ, Rodríguez-Pérez JC, Macías-Reyes A, Alamo-Santana F, (2003) Peroxisome proliferator-activated receptor-gamma2-Pro12Ala and endothelial nitric oxide synthase-4a/bgene polymorphisms are associated with essential hypertension. J Hypertens 21: 1649-1655.
23. Rossi GP, Taddei S, Virdis A, Cavallin M, Ghiadoni L, et al. (2003) The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients. J Am Coll Cardiol 41: 938-945.
24. Nagib El-Kilany GE, Nayel E, Hazzaa S, (2004) Nitric oxide synthase gene G298 allele. Is it a marker for microvascular angina in hypertensive patients? Cardiovasc Radiat Med 5: 113-118.
25. Kishimoto T, Misawa Y, Kaetu A, Nagai M, Osaki Y, et al. (2004) eNOS Glu298Asp polymorphism and hypertension in a cohort study in Japanese. Prev Med 39: 927-931.
26. Heltianu C, Costache G, Gafencu A, Diaconu M, Bodeanu M, et al. (2005) Relationship of eNOS gene variants to diseases that have in common an endothelial cell dysfunction. J Cell Mol Med 9: 135-142.
27. Wolff B, Grabe HJ, Schlüter C, Popowski K, Völzke H, et al. (2005) Endothelial nitric oxide synthase Glu298Asp gene polymorphism, blood pressure and hypertension in a general population sample. J Hypertens 23: 1361-1366.
28. Czarnecka D, Kawecka-Jaszcz K, Stolarz K, Olszanecka A, et al. (2005) Ambulatory blood pressure, left ventricular mass and vascular phenotypes in relation to the endothelial nitric oxide synthase gene Glu298Asp and intron 4 polymorphisms in a population-based family study. J Hum Hypertens 19: 413-420.
29. Djurić T, Zivković M, Stanković A, Mecanin S, Alavantić D, (2005) Endothelial NOS G894 T and MMP-3 5A/6A gene polymorphisms and hypertension in Serbian population. J Clin Lab Anal 19: 241-246.
30. Gouni-Berthold I, Giannakidou E, Müller-Wieland D, Faust M, Kotzka J, et al. (2005) Peroxisome proliferator-activated receptor-gamma2 Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are not associated with hypertension in diabetes mellitus type 2. J Hypertens 23: 301-308.
31. Demirel S, Akkaya V, Cine N, Oflaz H, Yekeler E, et al. (2005) Genetic polymorphisms and endothelial dysfunction in patients with essential hypertension: a crosssectional case-control study. Neth Heart J 13: 126-131.
32. Sandrim VC, Coelho EB, Nobre F, Arado GM, Lanchote VL, Tanus-Santos JE, (2006) Susceptible and protective eNOS haplotypes in hypertensive black and white subjects. Atherosclerosis 186: 428-432.
33. Zhao Q, Su SY, Chen SF, Li B, Gu DF, (2006) Association study of the endothelial nitric oxide synthase gene polymorphisms with essential hypertension in northern Han Chinese. Chin Med J (Engl) 119: 1065-1071.
34. Moe KT, Lim ST, Wong P, Chua T, DeSilva DA, et al. (2006) Association analysis of endothelial nitric oxide synthase gene polymorphism with primary hypertension in a Singapore population. J Hum Hypertens 20: 956-963.
35. Olcay A, Ekmekci CG, Ozbek U, Sezer M, Barcin C, et al. (2006) Negative association of endothelial nitric oxide gene polymorphism with hypertension in Turkish patients: effect of ecNOS polymorphism on left ventricular hypertrophy. Cardiovasc Ultrasound 4: 33.
36. Deng F, Hu Q, Tang B, He F, Guo S, et al. (2007) Endothelial nitric oxide synthase gene intron 4, 27 bp repeat polymorphism and essential hypertension in the Kazakh Chinese population. Acta Biochim Biophys Sin (Shanghai) 39: 311-316.
37. Tang W, Yang Y, Wang B, Xiao C, (2008) Association between a G894T polymorphism of eNOS gene and essential hypertension in Hani and Yi minority groups of China. Arch Med Res 39: 222-225.
38. Periaswamy R, Gurusamy U, Shewade DG, Cherian A, Swaminathan RP, et al. (2008) Gender specific association of endothelial nitric oxide synthase gene (Glu298Asp) polymorphism with essential hypertension in a south Indian population. Clin Chim Acta 395: 134-136.
39. Ghazali DM, Rehman A, Rahman AR, (2008) Candidate gene polymorphisms and their association with hypertension in Malays. Clin Chim Acta 388: 46-50.
40. Srivastava K, Narang R, Sreenivas V, Das S, Das N, (2008) Association of eNOS Glu298Asp gene polymorphism with essential hypertension in Asian Indians. Clin Chim Acta 387: 80-83.
41. Kobashi G, Ohta K, Yamada H, Hata A, Minakami H, et al. (2009) 4G/5G variant of plasminogen activator inhibitor-1 gene and severe pregnancy-induced hypertension: subgroup analyses of variants of angiotensinogen and endothelial nitric oxide synthase. J Epidemiol 19: 275-280.
42. Niu WQ, Qi Y, Zhang LT, Qi YX, Wang B, et al. (2009) Endothelial nitric oxide synthase genetic variation and essential hypertension risk in Han Chinese: the Fangshan study. J Hum Hypertens 23: 136-139.
43. Jemaa R, Ben Ali S, Kallel A, Feki M, Elasmi M, et al. (2009) Association of a 27-bp repeat polymorphism in intron 4 of endothelial constitutive nitric oxide synthase gene with hypertension in a Tunisian population. Clin Biochem 42: 852-856.
44. Patkar S, Charita BH, Ramesh C, Padma T, (2009) High risk of essential hypertension in males with intron 4 VNTR polymorphism of eNOS gene. Indian J Hum Genet 15: 49-53.
45. Vasconcellos V, Lacchini R, Jacob-Ferreira AL, Sales ML, Ferreira-Sae MC, et al. (2010) Endothelial nitric oxide synthase haplotypes associated with hypertension do not predispose to cardiac hypertrophy. DNA Cell Biol 29: 171-176.
46. Kingah PL, Luu HN, Volcik KA, Morrison AC, Nettleton JA, Boerwinkle E, (2010) Association of NOS3 Glu298Asp SNP with hypertension and possible effect modification of dietary fat intake in the ARIC study. Hypertens Res 33: 165-169.
47. Kitsios GD, Zintzaras E, (2010) An NOS3 Haplotype is Protective against Hypertension in a Caucasian Population. Int J Hypertens 2010: 865031.
48. Sediri Y, Kallel A, Ayadi I, Feki M, Elasmi M, et al. (2010) Lack of association between endothelial nitric oxide synthase gene G894T polymorphism hypertension in the Tunisian population. Prev Med 51: 88-89.
49. Zintzaras E, Kitsios G, Stefanidis I, (2006) Endothelial NO synthase gene polymorphisms and hypertension: a meta-analysis. Hypertension 48: 700-710.
50. Pereira TV, Rudnicki M, Cheung BM, Baum L, Yamada Y, et al. (2007) Three endothelial nitric oxide (NOS3) gene polymorphisms in hypertensive and normotensive individuals: meta-analysis of 53 studies reveals evidence of publication bias. J Hypertens 25: 1763-1774.
51. Niu W, Qi Y, Hou S, Zhai X, Zhou W, Qiu C, (2009) Haplotype-based association of the renin-angiotensin-aldosterone system genes polymorphisms with essential hypertension among Han Chinese: the Fangshan study. J Hypertens 27: 1384-1391.
52. Sandrim VC, Coelho EB, Nobre F, Arado GM, Lanchote VL, Tanus-Santos JE, (2006) Susceptible and protective eNOS haplotypes in hypertensive black and white subjects. Atherosclerosis 186: 428-432.
53. Wang XL, Mahaney MC, Sim AS, Wang J, Wang J, et al. (1997) Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol 17: 3147-3153.
54. Munafò MR, Flint J, (2004) Meta-analysis of genetic association studies. Trends Genet 20: 439-444.
55. DiPietro NA, (2010) Methods in epidemiology: observational study designs. Pharmacotherapy 30: 973-984.